Comparison Between Virtual vs in Person on Treatment Follow-up Visits of Radiotherapy
Transforming On-Treatment Follow-Up Care: A Randomized Controlled Trial of Virtual Versus In-Person Visits Evaluating Clinical Outcomes, Patient-Reported Measures, and Telehealth Implementation
1 other identifier
observational
180
1 country
1
Brief Summary
This study aims to evaluate the logistical feasibility and implementation of virtual versus in-person on-treatment follow up visits in a high-volume radiation oncology setting. It further seeks to assess and compare patient and physician satisfaction with both modalities through structured survey data, providing insight into the clinical utility, communication quality, and overall acceptability of telehealth integration during active cancer treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2026
CompletedFirst Submitted
Initial submission to the registry
June 24, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 15, 2026
July 24, 2026
June 1, 2026
4 months
June 24, 2026
July 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Outcomes of virtual vs in person on treatment of follow-up radiotherapy visits through structured questionnaire
To evaluate the implementation of virtual and in person follow-up visits thereby accessing and comparing patient satisfaction with both modalities through structured questionnaire providing insights into clinical utility and overall acceptability of telehealth integration during active cancer treatment.
4 weeks
Study Arms (2)
Inperson followup visits
Group A involves weekly in person followup visits in radiation department undergoing radiotherapy.
Hybrid virtual & inperson radiotherpay followup
Group B involves hybrid group with alternating 1 virtual and 1 in person followup visits in radiation department undergoing radiotherapy.
Eligibility Criteria
All cancer patients requiring radiotherapy
You may qualify if:
- Patients who are 18 years and above.
- All patients who are undergoing radiotherapy (\>5 fractions).
- Capacity to provide informed consent for participation in the study.
You may not qualify if:
- Patients below 18 years
- Unable to provide informed consent for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shaukat Khanum Memorial Cancer hospital & Research Centre
Lahore, Punjab Province, Pakistan
Related Publications (1)
Latif A, Usmani S, Sheikh A, et al. Bridging oncology gaps with telemedicine in low-resource settings. J Glob Oncol. 2023;9:1-8.
BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2026
First Posted
July 24, 2026
Study Start
May 11, 2026
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
October 15, 2026
Last Updated
July 24, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share